2008
DOI: 10.3748/wjg.14.4540
|View full text |Cite
|
Sign up to set email alerts
|

Radiofrequency ablation as a treatment for hilar cholangiocarcinoma

Abstract: AIM:To explore the role of radio-frequency ablation (RFA) as a treatment for hilar cholangiocarcinoma. M E T H O D S :E l e v e n p a t i e n t s w i t h o b s t r u c t i v e cholestasis underwent Computed Tomography (CT) examination, occupying lesions were observed in the hepatic hilar region in each patient. All lesions were confirmed as cholangioadenocarcinoma by biopsy and were classified as type Ⅲ or Ⅳ by percutaneous transhepatic cholangiography. Patients were treated with multiple electrodes RFA combin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(12 citation statements)
references
References 25 publications
0
12
0
Order By: Relevance
“…This is especially true for IRE application at higher voltages and pulse numbers, where some have reported tissue changes resembling the "white zone" (28) thermal coagulation seen with radiofrequency and other forms of thermal ablation (29). Given the fact that the M inimally invasive percutaneous (1-3) thermal tumor ablation is now an established treatment option for focal solid tumors in the liver (4-6), kidney (7), bone (8), and lung (9), with ever-expanding indications for focal tumors in additional locations (10)(11)(12). Yet improvements are necessary as treatment efficacy decreases for larger tumors (3-5 cm) (13).…”
Section: Overview Of Experimental Designmentioning
confidence: 98%
“…This is especially true for IRE application at higher voltages and pulse numbers, where some have reported tissue changes resembling the "white zone" (28) thermal coagulation seen with radiofrequency and other forms of thermal ablation (29). Given the fact that the M inimally invasive percutaneous (1-3) thermal tumor ablation is now an established treatment option for focal solid tumors in the liver (4-6), kidney (7), bone (8), and lung (9), with ever-expanding indications for focal tumors in additional locations (10)(11)(12). Yet improvements are necessary as treatment efficacy decreases for larger tumors (3-5 cm) (13).…”
Section: Overview Of Experimental Designmentioning
confidence: 98%
“…Unintended thermal injuries to the bile ducts, gall bladder, adrenal gland, diaphragmatic crus, and liver have all been described in the literature. The proximity of surrounding vital structures and the potential for immediate and late injury should be considered in every case .…”
Section: Radiofrequency Ablationmentioning
confidence: 99%
“…We have shown in our previously published studies a wide range of thermal sensitivity among tissues subject to RF ablation [11], and that the classic equations used for hyperthermia applications, like CEM 43 may not be as useful for much higher temperature ranges observed during thermal ablations [12]. Particularly, in that recent study performed with a single cooled tip RF electrode, the thermal dosimetry (as measured by [AUC]) was not constant, but both current-dependent and distance-dependent.…”
Section: Discussionmentioning
confidence: 99%
“…In many cases, these techniques allow one to avoid major surgery, that otherwise would have been required for removal of malignancy or enable treatment for non-surgical candidates [2,3]. Owing to advancements in both imaging modalities used for visualization and percutaneous devices used for delivery of energy into tumor tissue, these techniques have established themselves as viable treatment options for eradication of solid tumors in locations such as the liver [4,5,6], kidney [7], bone [8], lung [9], with ever expanding utility to additional locations including head and neck [10], adrenals, prostate and others [11,12]. …”
Section: Introductionmentioning
confidence: 99%